<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR103">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lombardo</surname>
    <given-names>LJ</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>FY</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Norris</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Barrish</surname>
    <given-names>JC</given-names>
   </name>
   <name>
    <surname>Behnia</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays</article-title>
  <source>J Medicinal Chem</source>
  <year>2004</year>
  <volume>47</volume>
  <fpage>6658</fpage>
  <lpage>61</lpage>
  <pub-id pub-id-type="doi">10.1021/jm049486a</pub-id>
 </element-citation>
</ref>
